Skip to main content
. 2014 May 13;17(1):18945. doi: 10.7448/IAS.17.1.18945

Table 4.

Variables predicting subclinical atherosclerosis in non-diabetic men with HIV infection

Multiple stepwise regression

Mean right CC IMT Maximum right CC IMT


B r2 p B r2 p
0.45 <0.001 0.26 0.03
Age (10 years) 0.06 0.004 0.05 0.05
Duration of HIV (years)
HIV-VL RNA/mL <39 (yes)
PIs exposure (years) 0.02 0.001 0.014 0.03
NRTI exposure (years) −0.07 0.2
NNRTI exposure (years)
BMI (kg/m2) −0.002 0.7 0.007 0.3
WHR −0.06 0.8 −0.31 0.4
Lipodystrophy (yes) −0.02 0.5 0.016 0.7
FG (mmol/L)
HbA1c (%) 0.07 0.058 0.07 0.14
IFG (yes) 0.03 0.3
TG (mmol/L)
hsRCP (mg/dL) 0.04 0.3
PAI-1 (ng/L) 0.01 0.1 0.01 0.1
IL-6 (pg/L)
Vitamin D insufficiency (yes) −0.03 0.4 −0.01 0.8
Constant 0.12 0.6 0.26 0.3
Mean left CC IMT Maximum left CC IMT


B r 2 p B r 2 p

0.44 0.003 0.48 <0.001
Age (10 years) 0.05 0.01 0.07 0.004
Duration of HIV (years) −0.02 0.6 −0.006 0.8
HIV-VL RNA/mL <39 cop.(yes) −0.03 0.4 −0.02 0.5
PIs exposure (years) 0.007 0.2 0.01 0.3
NRTI exposure (years) 0.006 0.3 0.01 0.35
NNRTI exposure (years) −0.005 0.6
BMI (kg/m2) −0.003 0.5
WHR 0.04 0.9 −0.32 0.2
Lipodystrophy (yes) −0.03 0.4 −0.02 0.5
FG (mmol/L) −0.003 0.2 0.005 0.13
HbA1c (%) 0.05 0.1 0.06 0.1
IFG (yes) 0.1 0.03 0.13 0.01
TG (mmol/L) 0.0001 0.4
hsRCP (mg/L) −0.00001 0.9
PAI-1 basal (ng/L) 0.006 0.2 0.009 0.07
IL-6 (pg/L) 0.004 0.2 0.006 0.1
Vitamin D insufficiency (yes) −0.01 0.8 −0.04 0.39
Constant 0.46 0.12 0.77 0.02

Dependent variables are in bold; explanatory variables with statistically significant results in multiple regression analysis and their significance are in bold. CC, common carotid; IMT, intima-media thickness; B, standardized coefficient; r2, coefficient of determination; BMI, body mass index; WHR, waist-hip ratio; NRTI, nucleoside reverse transcriptase inhibitor; PI, protease inhibitor; FG, fasting glucose; IFG, impaired fasting glucose (plasma glucose ≥5.55 mmol/L); TG, triglycerides; hsRCP, high-sensitivity reactive C protein; PAI-1, plasminogen activator inhibitor-1; IL-6, interleukin 6.